Rang	Name	Position
1	Dr. Andre Choulika Ph.D.	Co-Founder, CEO & Director
2	Dr. David J. Sourdive Ph.D.	Co-Founder, Deputy CEO, Executive VP of CMC & Manufacturing and Director
3	Mr. Arthur Stril	CFO & Chief Business Officer
4	Valerie Cros	Principal Financial Officer & Principal Accounting Officer
5	Mr. Jean Charles Epinat Ph.D.	Chief Technological Officer
6	Dr. Philippe Duchateau Ph.D.	Chief Scientific Officer
7	Ms. Marie-Bleuenn Terrier	General Counsel & Secretary of the Board of Directors
8	Pascalyne Wilson	Director of Communications
9	Ms. Kyung Nam-Wortman	Executive VP & Chief Human Resources Officer
10	Mr. Stephan Reynier M.Sc.	Chief Regulatory & Pharmaceutical Compliance Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	B Group, Inc	3,26%	10,17 Mio. USD
2	UBS Asset Mgmt Americas Inc	3,16%	9,85 Mio. USD
3	Long Focus Capital Management, LLC	2,72%	8,50 Mio. USD
4	BlackRock Inc	0,34%	1,06 Mio. USD
5	Delaware Management Holdings Inc	0,23%	0,70 Mio. USD
6	Morgan Stanley - Brokerage Accounts	0,09%	0,27 Mio. USD
7	LPL Financial Corp	0,08%	0,26 Mio. USD
8	Susquehanna International Group, LLP	0,07%	0,21 Mio. USD
9	Marshall Wace Asset Management Ltd	0,04%	0,13 Mio. USD
10	BNP Paribas Arbitrage, SA	0,04%	0,13 Mio. USD
11	UBS Group AG	0,03%	0,09 Mio. USD
12	Delaney Dennis R	0,02%	0,07 Mio. USD
13	XTX Topco Ltd	0,02%	0,05 Mio. USD
14	Rhumbline Advisers	0,02%	0,05 Mio. USD
15	Lido Advisors, LLC	0,01%	0,03 Mio. USD
16	HARBOUR INVESTMENTS, INC.	0,00%	0,01 Mio. USD
17	NATIONAL BANK OF CANADA /FI/	0,00%	0,01 Mio. USD
18	Wells Fargo & Co	0,00%	0,01 Mio. USD
19	Tower Research Capital LLC	0,00%	0,01 Mio. USD
20	Atlantic Union Bankshares Corp	0,00%	0,01 Mio. USD